Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Omega Funds
Biotech
Cure Ventures unveils inaugural $350M fund
Cure Ventures is unveiling its inaugural $350 million fund after launching in 2021.
Max Bayer
Apr 4, 2023 7:00am
SPAC fervor dwindles as biotechs get 'realistic and pragmatic'
Feb 7, 2022 10:20am
Endeavor nabs $101M for IPF, cancer trials—and asset shopping
Feb 7, 2022 8:00am
2022 forecast: In biopharma talent wars, everybody has offers
Dec 22, 2021 3:00am
Omega closes 7th fund at $650M to build Boston, Europe biotechs
Dec 17, 2021 8:00am
Software for the DNA hardware: Chroma snags $125M for epigenome
Nov 17, 2021 6:00am